abstract |
A preventive and/or therapeutic medicine for rheumatoid arthritis, comprising 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one and methotrexate. This medicine can be administered orally, being less in side effects, and exhibits excellent potency for arthritis suppression. |